Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

5 results

Filters applied: . Clear all
Page 1
Chronic thromboembolic pulmonary hypertension and clot resolution after COVID-19-associated pulmonary embolism.
de Jong CMM, Visser C, Bemelmans RHH, Boersma WG, van den Borst B, Burggraaf JLI, Cannegieter SC, Ten Cate-Hoek AJ, Croles FN, Faber HJ, Faber LM, Hellemons ME, Hessels LM, Huisman MV, Kamphuisen PW, Koster SCE, Kroft LJM, van der Lee I, Leentjens J, Meijer K, Ninaber MK, Sondermeijer BM, Stads S, Vonk Noordegraaf A, Winckers K, Kruip MJHA, Klok FA; Dutch COVID & Thrombosis Coalition investigators. de Jong CMM, et al. Among authors: kruip mjha. Eur Respir J. 2023 Apr 20;61(4):2300171. doi: 10.1183/13993003.00171-2023. Print 2023 Apr. Eur Respir J. 2023. PMID: 37080574 Free PMC article.
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE in non-COVID-19 patients, and thrombus resolution did not seem to be different from non-COVID-19-associated PE https://bit.ly/3IjvWL3 The inc …
The results of this study suggest that CTEPH is not a more common long-term complication after COVID-19-associated PE than after PE i …
Short-term prognosis of breakthrough venous thromboembolism in anticoagulated patients.
van Es J, Cheung YW, van Es N, Klok FA, Dronkers CEA, Ten Wolde M, Kruip MJHA, Huisman MV, Meijer K, Kamphuisen PW, Gerdes VEA, Middeldorp S. van Es J, et al. Among authors: kruip mjha. Thromb Res. 2020 Mar;187:125-130. doi: 10.1016/j.thromres.2020.01.010. Epub 2020 Jan 20. Thromb Res. 2020. PMID: 31986475 Free article.
Statin use decreases coagulation in users of vitamin K antagonists.
van Rein N, Biedermann JS, Bonafacio SM, Kruip MJ, van der Meer FJ, Lijfering WM. van Rein N, et al. Among authors: kruip mj. Eur J Clin Pharmacol. 2016 Dec;72(12):1441-1447. doi: 10.1007/s00228-016-2138-6. Epub 2016 Oct 5. Eur J Clin Pharmacol. 2016. PMID: 27709253 Free PMC article. Clinical Trial.
PURPOSE: The purpose of the study is to determine the immediate and long-term effect of statins on coagulation in patients treated with vitamin K antagonists (VKAs). ...The VKA dosage (mg/day) after statin initiation was compared with the last VKA dosage before the statin …
PURPOSE: The purpose of the study is to determine the immediate and long-term effect of statins on coagulation in patients treated wi …
Control of anticoagulation with vitamin K antagonists: overestimation of median time in therapeutic range when assessed by linear interpolation.
van den Besselaar AM, Biedermann JS, van der Meer FJ, Adriaansen HJ, Leebeek FW, Kruip MJ. van den Besselaar AM, et al. Among authors: kruip mj. Thromb Haemost. 2016 Sep 27;116(4):679-86. doi: 10.1160/TH16-03-0184. Epub 2016 Jul 7. Thromb Haemost. 2016. PMID: 27384264
Different groups of around 400,000 patients in four consecutive years were evaluated: patients in the induction phase, short-term, long-term, low-target range, high-target range, receiving either acenocoumarol or phenprocoumon, and performing self-management. ...In …
Different groups of around 400,000 patients in four consecutive years were evaluated: patients in the induction phase, short-term, lo …